1. Home
  2. BDTX vs LCNB Comparison

BDTX vs LCNB Comparison

Compare BDTX & LCNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • LCNB
  • Stock Information
  • Founded
  • BDTX 2014
  • LCNB 1877
  • Country
  • BDTX United States
  • LCNB United States
  • Employees
  • BDTX N/A
  • LCNB N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • LCNB Major Banks
  • Sector
  • BDTX Health Care
  • LCNB Finance
  • Exchange
  • BDTX Nasdaq
  • LCNB Nasdaq
  • Market Cap
  • BDTX 181.4M
  • LCNB 205.5M
  • IPO Year
  • BDTX 2020
  • LCNB N/A
  • Fundamental
  • Price
  • BDTX $2.76
  • LCNB $15.05
  • Analyst Decision
  • BDTX Strong Buy
  • LCNB
  • Analyst Count
  • BDTX 5
  • LCNB 0
  • Target Price
  • BDTX $13.40
  • LCNB N/A
  • AVG Volume (30 Days)
  • BDTX 914.3K
  • LCNB 20.3K
  • Earning Date
  • BDTX 08-07-2025
  • LCNB 07-22-2025
  • Dividend Yield
  • BDTX N/A
  • LCNB 5.85%
  • EPS Growth
  • BDTX N/A
  • LCNB 186.06
  • EPS
  • BDTX 0.25
  • LCNB 1.49
  • Revenue
  • BDTX $70,000,000.00
  • LCNB $86,864,000.00
  • Revenue This Year
  • BDTX N/A
  • LCNB N/A
  • Revenue Next Year
  • BDTX N/A
  • LCNB $6.72
  • P/E Ratio
  • BDTX $11.03
  • LCNB $10.10
  • Revenue Growth
  • BDTX N/A
  • LCNB 22.73
  • 52 Week Low
  • BDTX $1.20
  • LCNB $13.34
  • 52 Week High
  • BDTX $6.75
  • LCNB $17.92
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 52.31
  • LCNB 50.80
  • Support Level
  • BDTX $2.22
  • LCNB $14.33
  • Resistance Level
  • BDTX $2.84
  • LCNB $15.69
  • Average True Range (ATR)
  • BDTX 0.20
  • LCNB 0.43
  • MACD
  • BDTX -0.01
  • LCNB 0.04
  • Stochastic Oscillator
  • BDTX 72.00
  • LCNB 57.67

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About LCNB LCNB Corporation

LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.

Share on Social Networks: